Hess KR - Search Results

1

Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.

Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR, Zhang W, Fidler IJ, Chiao PJ. Sclabas GM, et al. Among authors: hess kr. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):440-9. Clin Cancer Res. 2005. PMID: 15701826

2

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Abbruzzese JL, et al. Among authors: hess kr. J Clin Oncol. 1995 Aug;13(8):2094-103. doi: 10.1200/JCO.1995.13.8.2094. J Clin Oncol. 1995. PMID: 7636553

3

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients.

Abbruzzese JL, Abbruzzese MC, Hess KR, Raber MN, Lenzi R, Frost P. Abbruzzese JL, et al. Among authors: hess kr. J Clin Oncol. 1994 Jun;12(6):1272-80. doi: 10.1200/JCO.1994.12.6.1272. J Clin Oncol. 1994. PMID: 8201389

4

Are time or intensity factors important to the definition of metastases of unknown origin?

Abbruzzese JL, Abbruzzese MC, Lenzi R, Raber MN, Hess KR. Abbruzzese JL, et al. Among authors: hess kr. J Natl Cancer Inst. 1996 Apr 3;88(7):462-3. doi: 10.1093/jnci/88.7.462-a. J Natl Cancer Inst. 1996. PMID: 8618241 No abstract available.

5

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Lenzi R, Hess KR, Abbruzzese MC, Raber MN, Ordoñez NG, Abbruzzese JL. Lenzi R, et al. Among authors: hess kr. J Clin Oncol. 1997 May;15(5):2056-66. doi: 10.1200/JCO.1997.15.5.2056. J Clin Oncol. 1997. PMID: 9164218

6

Unknown primary tumors metastatic to liver.

Ayoub JP, Hess KR, Abbruzzese MC, Lenzi R, Raber MN, Abbruzzese JL. Ayoub JP, et al. Among authors: hess kr. J Clin Oncol. 1998 Jun;16(6):2105-12. doi: 10.1200/JCO.1998.16.6.2105. J Clin Oncol. 1998. PMID: 9626210

7

Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance.

Lin H, Bondy ML, Langford LA, Hess KR, Delclos GL, Wu X, Chan W, Pershouse MA, Yung WK, Steck PA. Lin H, et al. Among authors: hess kr. Clin Cancer Res. 1998 Oct;4(10):2447-54. Clin Cancer Res. 1998. PMID: 9796977

8

p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.

Spitz FR, Giacco GG, Hess K, Larry L, Rich TA, Janjan N, Cleary KR, Skibber JM. Spitz FR, et al. Among authors: hess k. Clin Cancer Res. 1997 Oct;3(10):1685-90. Clin Cancer Res. 1997. PMID: 9815551

9

Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.

Ali-Osman F, Brunner JM, Kutluk TM, Hess K. Ali-Osman F, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2253-61. Clin Cancer Res. 1997. PMID: 9815622

10

Prognostic significance of p53 immunoreactivity in patients with glioma.

Kyritsis AP, Bondy ML, Hess KR, Cunningham JE, Zhu D, Amos CJ, Yung WK, Levin VA, Bruner JM. Kyritsis AP, et al. Among authors: hess kr. Clin Cancer Res. 1995 Dec;1(12):1617-22. Clin Cancer Res. 1995. PMID: 9815964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters